

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.60703367 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.60703367 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.34967141 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.34967141 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53775934 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.45863900 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.45863900 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.92205070 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.91510346 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.74928611 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71714152 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.70556578 |
| 13 | cysteine metabolic process (GO:0006534) | 4.70403399 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.57265217 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.55302735 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.52834459 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.51385470 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.39127741 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.36166229 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35821577 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.30761408 |
| 22 | creatine metabolic process (GO:0006600) | 4.27359376 |
| 23 | bile acid biosynthetic process (GO:0006699) | 4.24505974 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.13207963 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.04597677 |
| 26 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.99358642 |
| 27 | positive T cell selection (GO:0043368) | 3.91890503 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91774476 |
| 29 | heme transport (GO:0015886) | 3.88444779 |
| 30 | detection of other organism (GO:0098543) | 3.86498001 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.84925618 |
| 32 | detection of bacterium (GO:0016045) | 3.84919870 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.84292128 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.81091193 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.79912308 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.79912308 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.79912308 |
| 38 | bile acid metabolic process (GO:0008206) | 3.78606117 |
| 39 | lysine metabolic process (GO:0006553) | 3.77704904 |
| 40 | lysine catabolic process (GO:0006554) | 3.77704904 |
| 41 | response to peptidoglycan (GO:0032494) | 3.76977350 |
| 42 | tolerance induction (GO:0002507) | 3.75559577 |
| 43 | thymic T cell selection (GO:0045061) | 3.74139136 |
| 44 | negative T cell selection (GO:0043383) | 3.72964088 |
| 45 | glyoxylate metabolic process (GO:0046487) | 3.70114032 |
| 46 | leukocyte aggregation (GO:0070486) | 3.68639386 |
| 47 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68539909 |
| 48 | modulation by symbiont of host defense response (GO:0052031) | 3.68539909 |
| 49 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68539909 |
| 50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68539909 |
| 51 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68539909 |
| 52 | modulation by symbiont of host immune response (GO:0052553) | 3.68539909 |
| 53 | T cell selection (GO:0045058) | 3.65963825 |
| 54 | germinal center formation (GO:0002467) | 3.65595547 |
| 55 | heme biosynthetic process (GO:0006783) | 3.60713632 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.58589382 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.57787263 |
| 58 | complement activation, alternative pathway (GO:0006957) | 3.57496355 |
| 59 | urea metabolic process (GO:0019627) | 3.55777849 |
| 60 | urea cycle (GO:0000050) | 3.55777849 |
| 61 | tryptophan metabolic process (GO:0006568) | 3.50883536 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 3.47851174 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.46823027 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.46164062 |
| 65 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.45721191 |
| 66 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.45636018 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 3.43802165 |
| 68 | aromatic amino acid family metabolic process (GO:0009072) | 3.43616448 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 3.42162634 |
| 70 | response to mercury ion (GO:0046689) | 3.41942272 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 3.41594119 |
| 72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40577833 |
| 73 | glycine metabolic process (GO:0006544) | 3.40192064 |
| 74 | coenzyme catabolic process (GO:0009109) | 3.40186216 |
| 75 | cofactor catabolic process (GO:0051187) | 3.39934298 |
| 76 | central nervous system myelination (GO:0022010) | 3.39628481 |
| 77 | axon ensheathment in central nervous system (GO:0032291) | 3.39628481 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.39586817 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 3.39335502 |
| 80 | heme metabolic process (GO:0042168) | 3.38643318 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.36466989 |
| 82 | regulation of protein activation cascade (GO:2000257) | 3.36227561 |
| 83 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36028406 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 3.35964258 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 3.35067045 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 3.33880501 |
| 87 | valine metabolic process (GO:0006573) | 3.31627581 |
| 88 | fatty acid catabolic process (GO:0009062) | 3.31085552 |
| 89 | response to interleukin-15 (GO:0070672) | 3.29770242 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.29530041 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 3.28992774 |
| 92 | porphyrin-containing compound metabolic process (GO:0006778) | 3.28554623 |
| 93 | alpha-amino acid catabolic process (GO:1901606) | 3.28529611 |
| 94 | B cell receptor signaling pathway (GO:0050853) | 3.27855762 |
| 95 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25512712 |
| 96 | amino-acid betaine metabolic process (GO:0006577) | 3.24609267 |
| 97 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.24427500 |
| 98 | negative regulation of sterol transport (GO:0032372) | 3.23932586 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 3.23932586 |
| 100 | protein-lipid complex assembly (GO:0065005) | 3.22463653 |
| 101 | protein carboxylation (GO:0018214) | 3.20915218 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.20915218 |
| 103 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19330205 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 3.19271115 |
| 105 | cellular amino acid catabolic process (GO:0009063) | 3.18797397 |
| 106 | negative regulation of fibrinolysis (GO:0051918) | 3.17255373 |
| 107 | fatty acid transmembrane transport (GO:1902001) | 3.15723761 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.15721908 |
| 109 | regulation of complement activation (GO:0030449) | 3.15575434 |
| 110 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14791295 |
| 111 | tetrapyrrole biosynthetic process (GO:0033014) | 3.14034610 |
| 112 | glutamate metabolic process (GO:0006536) | 3.13536679 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 3.12671491 |
| 114 | cellular extravasation (GO:0045123) | 3.12520024 |
| 115 | regulation of T cell tolerance induction (GO:0002664) | 3.12051018 |
| 116 | monocarboxylic acid catabolic process (GO:0072329) | 3.09685172 |
| 117 | regulation of cholesterol metabolic process (GO:0090181) | 3.08125135 |
| 118 | response to methylmercury (GO:0051597) | 3.07876527 |
| 119 | ethanol oxidation (GO:0006069) | 3.06922723 |
| 120 | fatty acid oxidation (GO:0019395) | 3.06918126 |
| 121 | triglyceride homeostasis (GO:0070328) | 3.05365951 |
| 122 | acylglycerol homeostasis (GO:0055090) | 3.05365951 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.03600997 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.03600997 |
| 125 | carboxylic acid catabolic process (GO:0046395) | 3.03365461 |
| 126 | organic acid catabolic process (GO:0016054) | 3.03365461 |
| 127 | mannose metabolic process (GO:0006013) | 3.02158860 |
| 128 | detection of external biotic stimulus (GO:0098581) | 3.02149822 |
| 129 | very long-chain fatty acid metabolic process (GO:0000038) | 3.01110436 |
| 130 | regulation of cholesterol esterification (GO:0010872) | 3.00801003 |
| 131 | plasma lipoprotein particle assembly (GO:0034377) | 3.00791608 |
| 132 | carnitine shuttle (GO:0006853) | 2.99976425 |
| 133 | negative regulation of innate immune response (GO:0045824) | 2.99641174 |
| 134 | regulation of B cell differentiation (GO:0045577) | 2.99627215 |
| 135 | lipid oxidation (GO:0034440) | 2.99379699 |
| 136 | fatty acid elongation (GO:0030497) | 2.97514444 |
| 137 | T cell migration (GO:0072678) | 2.97396126 |
| 138 | regulation of tolerance induction (GO:0002643) | 2.97134161 |
| 139 | positive regulation of Rap GTPase activity (GO:0032854) | 2.94481985 |
| 140 | membrane tubulation (GO:0097320) | 2.94449320 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94347216 |
| 142 | regulation of fibrinolysis (GO:0051917) | 2.94212427 |
| 143 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93003105 |
| 144 | biotin metabolic process (GO:0006768) | 2.92996307 |
| 145 | protein-lipid complex remodeling (GO:0034368) | 2.92496097 |
| 146 | macromolecular complex remodeling (GO:0034367) | 2.92496097 |
| 147 | plasma lipoprotein particle remodeling (GO:0034369) | 2.92496097 |
| 148 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.90639875 |
| 149 | tyrosine metabolic process (GO:0006570) | 2.90587427 |
| 150 | cellular ketone body metabolic process (GO:0046950) | 2.89799347 |
| 151 | regulation of leukocyte degranulation (GO:0043300) | 2.89381942 |
| 152 | cholesterol efflux (GO:0033344) | 2.88759374 |
| 153 | L-serine metabolic process (GO:0006563) | 2.87690723 |
| 154 | cellular modified amino acid catabolic process (GO:0042219) | 2.87565097 |
| 155 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87554073 |
| 156 | neutrophil activation (GO:0042119) | 2.86491162 |
| 157 | type I interferon signaling pathway (GO:0060337) | 2.86346669 |
| 158 | cellular response to type I interferon (GO:0071357) | 2.86346669 |
| 159 | response to type I interferon (GO:0034340) | 2.86049966 |
| 160 | cholesterol homeostasis (GO:0042632) | 2.83838460 |
| 161 | phospholipid efflux (GO:0033700) | 2.83780703 |
| 162 | amine catabolic process (GO:0009310) | 2.82968805 |
| 163 | cellular biogenic amine catabolic process (GO:0042402) | 2.82968805 |
| 164 | myeloid cell activation involved in immune response (GO:0002275) | 2.82075227 |
| 165 | regulation of granulocyte differentiation (GO:0030852) | 2.82061897 |
| 166 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81657879 |
| 167 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.81355381 |
| 168 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.81355381 |
| 169 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80148431 |
| 170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79002135 |
| 171 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77600001 |
| 172 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.77581573 |
| 173 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.77258276 |
| 174 | granulocyte activation (GO:0036230) | 2.76043318 |
| 175 | cellular response to interleukin-15 (GO:0071350) | 2.75565758 |
| 176 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71545217 |
| 177 | defense response to protozoan (GO:0042832) | 2.69174557 |
| 178 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.68597551 |
| 179 | activated T cell proliferation (GO:0050798) | 2.66846116 |
| 180 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65509154 |
| 181 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65509154 |
| 182 | respiratory burst (GO:0045730) | 2.63822446 |
| 183 | positive regulation of tolerance induction (GO:0002645) | 2.61874385 |
| 184 | detection of biotic stimulus (GO:0009595) | 2.61261715 |
| 185 | regulation of antigen processing and presentation (GO:0002577) | 2.60847082 |
| 186 | macrophage activation (GO:0042116) | 2.58535200 |
| 187 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58464863 |
| 188 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.57877708 |
| 189 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.57439869 |
| 190 | negative regulation of interleukin-6 production (GO:0032715) | 2.56803962 |
| 191 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55913109 |
| 192 | B cell homeostasis (GO:0001782) | 2.55519553 |
| 193 | response to host immune response (GO:0052572) | 2.55317101 |
| 194 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55317101 |
| 195 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.54498464 |
| 196 | lymphocyte homeostasis (GO:0002260) | 2.53874406 |
| 197 | positive regulation of antigen processing and presentation (GO:0002579) | 2.53181021 |
| 198 | negative regulation of type 2 immune response (GO:0002829) | 2.52469039 |
| 199 | regulation of necroptotic process (GO:0060544) | 2.51821470 |
| 200 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.51564866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.92825239 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.92709918 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.47349664 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.82270891 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77333935 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.68195651 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.53791636 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.48033338 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.18182679 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.94336464 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.85861660 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.45632538 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40609602 |
| 14 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26560002 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.25491085 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12497061 |
| 17 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.10714250 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10229235 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.07594917 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03491255 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02537943 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02041014 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00242598 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.95236447 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94421676 |
| 26 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88998857 |
| 27 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.87282472 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.85178924 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84284464 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82425959 |
| 31 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.79332535 |
| 32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.75106369 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74402836 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74343381 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72850020 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67481633 |
| 37 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.63929461 |
| 38 | * MYC_22102868_ChIP-Seq_BL_Human | 1.52750477 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50726426 |
| 40 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49204453 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48870320 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45504445 |
| 43 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44721251 |
| 44 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43556532 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40540024 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40435618 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38643591 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38447703 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36650156 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36534859 |
| 51 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36145601 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36011951 |
| 53 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33595379 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31642257 |
| 55 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31031391 |
| 56 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30653308 |
| 57 | * MAF_26560356_Chip-Seq_TH1_Human | 1.29663252 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29528335 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27202544 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26941329 |
| 61 | * STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26883562 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26810628 |
| 63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26440976 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25954175 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25651781 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25269979 |
| 67 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.24374529 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23676390 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.22532846 |
| 70 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.21673219 |
| 71 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21414690 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20924887 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20890941 |
| 74 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19947570 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19935154 |
| 76 | * P68_20966046_ChIP-Seq_HELA_Human | 1.19492806 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17597584 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17562469 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17496742 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16907098 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16700545 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16588600 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14324594 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13195207 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13118559 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12072047 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11637476 |
| 88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10503268 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10000925 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09526435 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09212310 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09135235 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08071334 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06241585 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05291549 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04620545 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04593034 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04546809 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02856599 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02552987 |
| 101 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02049921 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01650554 |
| 103 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01647934 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01260724 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98767844 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95767630 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93646804 |
| 108 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93570985 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93253629 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93142373 |
| 111 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93099508 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92146965 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92016999 |
| 114 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.91727034 |
| 115 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91459547 |
| 116 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91310527 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91073147 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90906723 |
| 119 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90519937 |
| 120 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.90515626 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90244438 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89820876 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89676136 |
| 124 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89638935 |
| 125 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88965675 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88671739 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88505081 |
| 128 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.87888374 |
| 129 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87051018 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86938912 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86567719 |
| 132 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86323005 |
| 133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85201954 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.85175971 |
| 135 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84517925 |
| 136 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84289529 |
| 137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84090434 |
| 138 | P300_27268052_Chip-Seq_Bcells_Human | 0.84008218 |
| 139 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83693314 |
| 140 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81643087 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.81547120 |
| 142 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.80846218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.12634370 |
| 2 | MP0005360_urolithiasis | 4.87746041 |
| 3 | MP0009840_abnormal_foam_cell | 4.67086314 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.00447064 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.90559807 |
| 6 | MP0003656_abnormal_erythrocyte_physiolo | 3.87718806 |
| 7 | MP0005365_abnormal_bile_salt | 3.78092547 |
| 8 | MP0003303_peritoneal_inflammation | 3.33584527 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.15147989 |
| 10 | MP0003724_increased_susceptibility_to | 3.11083115 |
| 11 | MP0005083_abnormal_biliary_tract | 2.95088740 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.91113869 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.65539436 |
| 14 | MP0005451_abnormal_body_composition | 2.63967414 |
| 15 | MP0004147_increased_porphyrin_level | 2.49724042 |
| 16 | MP0003646_muscle_fatigue | 2.29100672 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.27804513 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.26793755 |
| 19 | MP0001819_abnormal_immune_cell | 2.23842123 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.23477445 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.22406370 |
| 22 | MP0009785_altered_susceptibility_to | 2.20575956 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.15513077 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.12501938 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.07166832 |
| 26 | MP0004130_abnormal_muscle_cell | 2.05193431 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.03630260 |
| 28 | MP0009278_abnormal_bone_marrow | 2.03092744 |
| 29 | MP0003252_abnormal_bile_duct | 2.02842073 |
| 30 | MP0000609_abnormal_liver_physiology | 2.00968160 |
| 31 | MP0002405_respiratory_system_inflammati | 1.95249850 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.93546578 |
| 33 | MP0005332_abnormal_amino_acid | 1.91462172 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.90432454 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.90026197 |
| 36 | MP0000747_muscle_weakness | 1.83480537 |
| 37 | MP0000716_abnormal_immune_system | 1.79430654 |
| 38 | MP0000749_muscle_degeneration | 1.77651742 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.76193665 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.74528956 |
| 41 | MP0000920_abnormal_myelination | 1.71742734 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.70588631 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.67528721 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62975949 |
| 45 | MP0003828_pulmonary_edema | 1.60958085 |
| 46 | MP0003195_calcinosis | 1.57776547 |
| 47 | MP0003866_abnormal_defecation | 1.51914656 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.51194317 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.49012071 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.46840340 |
| 51 | MP0002429_abnormal_blood_cell | 1.45063584 |
| 52 | MP0002269_muscular_atrophy | 1.44910986 |
| 53 | MP0000685_abnormal_immune_system | 1.42450663 |
| 54 | MP0001853_heart_inflammation | 1.42275521 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.40587323 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.40585728 |
| 57 | MP0003690_abnormal_glial_cell | 1.39242206 |
| 58 | MP0004381_abnormal_hair_follicle | 1.37722845 |
| 59 | MP0005670_abnormal_white_adipose | 1.35335985 |
| 60 | MP0003868_abnormal_feces_composition | 1.35311410 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.34617070 |
| 62 | MP0002933_joint_inflammation | 1.24877723 |
| 63 | MP0000604_amyloidosis | 1.23415241 |
| 64 | MP0008260_abnormal_autophagy | 1.22261854 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.21053892 |
| 66 | MP0002971_abnormal_brown_adipose | 1.20767008 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.16303036 |
| 68 | MP0002132_abnormal_respiratory_system | 1.15938006 |
| 69 | MP0006082_CNS_inflammation | 1.15357758 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.10664621 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 1.10033590 |
| 72 | MP0005334_abnormal_fat_pad | 1.09807297 |
| 73 | MP0000858_altered_metastatic_potential | 1.08922311 |
| 74 | MP0000598_abnormal_liver_morphology | 1.06489847 |
| 75 | MP0003329_amyloid_beta_deposits | 1.06433559 |
| 76 | MP0003436_decreased_susceptibility_to | 1.06182266 |
| 77 | MP0005166_decreased_susceptibility_to | 1.06075166 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.04146789 |
| 79 | MP0005375_adipose_tissue_phenotype | 1.03357031 |
| 80 | MP0009763_increased_sensitivity_to | 1.01974597 |
| 81 | MP0002106_abnormal_muscle_physiology | 1.00768601 |
| 82 | MP0008469_abnormal_protein_level | 1.00366186 |
| 83 | MP0000751_myopathy | 0.98134846 |
| 84 | MP0001764_abnormal_homeostasis | 0.96294427 |
| 85 | MP0000343_altered_response_to | 0.94225160 |
| 86 | MP0002009_preneoplasia | 0.92348503 |
| 87 | MP0000759_abnormal_skeletal_muscle | 0.91886232 |
| 88 | MP0009764_decreased_sensitivity_to | 0.90864996 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.90830196 |
| 90 | MP0004510_myositis | 0.90686862 |
| 91 | MP0001790_abnormal_immune_system | 0.90582082 |
| 92 | MP0005387_immune_system_phenotype | 0.90582082 |
| 93 | MP0003045_fibrosis | 0.90329026 |
| 94 | MP0004087_abnormal_muscle_fiber | 0.89619017 |
| 95 | MP0001661_extended_life_span | 0.86030164 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.85297378 |
| 97 | MP0001800_abnormal_humoral_immune | 0.84833574 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.84406512 |
| 99 | MP0004947_skin_inflammation | 0.83524831 |
| 100 | MP0002254_reproductive_system_inflammat | 0.82627976 |
| 101 | MP0003718_maternal_effect | 0.82155138 |
| 102 | MP0005310_abnormal_salivary_gland | 0.81963087 |
| 103 | MP0004883_abnormal_blood_vessel | 0.80234053 |
| 104 | MP0005266_abnormal_metabolism | 0.79938914 |
| 105 | MP0001663_abnormal_digestive_system | 0.79650799 |
| 106 | MP0005535_abnormal_body_temperature | 0.77823681 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.77804486 |
| 108 | MP0003091_abnormal_cell_migration | 0.77695893 |
| 109 | MP0000249_abnormal_blood_vessel | 0.77687548 |
| 110 | MP0008874_decreased_physiological_sensi | 0.77381079 |
| 111 | MP0003075_altered_response_to | 0.76646359 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.76486417 |
| 113 | MP0003448_altered_tumor_morphology | 0.75869249 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.75809954 |
| 115 | MP0005671_abnormal_response_to | 0.75015707 |
| 116 | MP0002723_abnormal_immune_serum | 0.74984128 |
| 117 | MP0003186_abnormal_redox_activity | 0.74660602 |
| 118 | MP0005164_abnormal_response_to | 0.74636923 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.74381201 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.74318548 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.73402705 |
| 122 | MP0005025_abnormal_response_to | 0.72891082 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.72830437 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71509524 |
| 125 | MP0009642_abnormal_blood_homeostasis | 0.70156404 |
| 126 | MP0003795_abnormal_bone_structure | 0.70148782 |
| 127 | MP0002006_tumorigenesis | 0.70002350 |
| 128 | MP0001873_stomach_inflammation | 0.68622447 |
| 129 | MP0003705_abnormal_hypodermis_morpholog | 0.68242984 |
| 130 | MP0005369_muscle_phenotype | 0.66259447 |
| 131 | MP0005647_abnormal_sex_gland | 0.65822468 |
| 132 | MP0005390_skeleton_phenotype | 0.65553700 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.64366686 |
| 134 | MP0002419_abnormal_innate_immunity | 0.64305440 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.64219080 |
| 136 | MP0002277_abnormal_respiratory_mucosa | 0.64165492 |
| 137 | MP0001851_eye_inflammation | 0.63413218 |
| 138 | MP0002722_abnormal_immune_system | 0.62851897 |
| 139 | MP0001835_abnormal_antigen_presentation | 0.62722960 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.62480669 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.62445360 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.62445360 |
| 143 | MP0002837_dystrophic_cardiac_calcinosis | 0.62215772 |
| 144 | MP0000750_abnormal_muscle_regeneration | 0.61941917 |
| 145 | MP0005330_cardiomyopathy | 0.61410174 |
| 146 | MP0003300_gastrointestinal_ulcer | 0.61309686 |
| 147 | MP0010368_abnormal_lymphatic_system | 0.60768914 |
| 148 | MP0002398_abnormal_bone_marrow | 0.60387305 |
| 149 | MP0003453_abnormal_keratinocyte_physiol | 0.60215885 |
| 150 | MP0009115_abnormal_fat_cell | 0.59425193 |
| 151 | MP0000015_abnormal_ear_pigmentation | 0.59159361 |
| 152 | MP0000733_abnormal_muscle_development | 0.59017699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.30217788 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.28840223 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.58578468 |
| 4 | Xanthomatosis (HP:0000991) | 4.57806061 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.44315360 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.33759137 |
| 7 | Myositis (HP:0100614) | 4.32026160 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.13275873 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.12380198 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.08405308 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93534381 |
| 12 | Stomatitis (HP:0010280) | 3.69459146 |
| 13 | Orchitis (HP:0100796) | 3.66982726 |
| 14 | Cholelithiasis (HP:0001081) | 3.61866075 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 3.61473523 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.50782864 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.46014982 |
| 18 | Optic neuritis (HP:0100653) | 3.46014982 |
| 19 | Abnormal gallbladder morphology (HP:0012437) | 3.45765433 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.44871115 |
| 21 | Pustule (HP:0200039) | 3.44411506 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.43644049 |
| 23 | Ketosis (HP:0001946) | 3.42524791 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.39236816 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.38866492 |
| 26 | Abnormal gallbladder physiology (HP:0012438) | 3.35331513 |
| 27 | Cholecystitis (HP:0001082) | 3.35331513 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33443566 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 3.27859153 |
| 30 | Exercise-induced myalgia (HP:0003738) | 3.27445149 |
| 31 | Meningitis (HP:0001287) | 3.26173204 |
| 32 | Complement deficiency (HP:0004431) | 3.22355575 |
| 33 | Recurrent skin infections (HP:0001581) | 3.17872994 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 3.15595747 |
| 35 | Nemaline bodies (HP:0003798) | 3.13788030 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13025986 |
| 37 | Obstructive lung disease (HP:0006536) | 3.13025986 |
| 38 | Muscle fiber splitting (HP:0003555) | 3.12795222 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.11379275 |
| 40 | Hyperammonemia (HP:0001987) | 3.11034211 |
| 41 | Spontaneous hematomas (HP:0007420) | 3.10005129 |
| 42 | Reticulocytosis (HP:0001923) | 3.08552613 |
| 43 | Axonal loss (HP:0003447) | 3.06938046 |
| 44 | Increased IgE level (HP:0003212) | 3.06186042 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 3.05608342 |
| 46 | Myoglobinuria (HP:0002913) | 3.01196577 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.00796256 |
| 48 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97908097 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.97397933 |
| 50 | Increased serum ferritin (HP:0003281) | 2.97223345 |
| 51 | Hyperbilirubinemia (HP:0002904) | 2.96633436 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95803430 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95803430 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.94334255 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 2.91779210 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.91386854 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.90334080 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.89356590 |
| 59 | Recurrent viral infections (HP:0004429) | 2.88222800 |
| 60 | Colitis (HP:0002583) | 2.85403971 |
| 61 | Cellulitis (HP:0100658) | 2.85259851 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.85234260 |
| 63 | Abnormality of glycine metabolism (HP:0010895) | 2.85234260 |
| 64 | Vasculitis (HP:0002633) | 2.84813855 |
| 65 | T lymphocytopenia (HP:0005403) | 2.84661794 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.84221652 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.83436535 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.83436535 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.83436535 |
| 70 | Hyperglycinemia (HP:0002154) | 2.81951094 |
| 71 | Hypolipoproteinemia (HP:0010981) | 2.81939506 |
| 72 | Poikilocytosis (HP:0004447) | 2.81697959 |
| 73 | Paralysis (HP:0003470) | 2.80417912 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.77829788 |
| 75 | Muscle stiffness (HP:0003552) | 2.77727412 |
| 76 | Encephalitis (HP:0002383) | 2.76985527 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.73787809 |
| 78 | Neurofibrillary tangles (HP:0002185) | 2.73160243 |
| 79 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.72173764 |
| 80 | Dysostosis multiplex (HP:0000943) | 2.71834722 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.69983103 |
| 82 | Ulnar deviation of the wrist (HP:0003049) | 2.69792007 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.69449584 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.68962034 |
| 85 | Myopathic facies (HP:0002058) | 2.67400383 |
| 86 | Acanthocytosis (HP:0001927) | 2.66759050 |
| 87 | Gingivitis (HP:0000230) | 2.59727389 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.57333028 |
| 89 | Abnormality of T cell number (HP:0011839) | 2.56471178 |
| 90 | Rhabdomyolysis (HP:0003201) | 2.56373175 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 2.55622378 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.50532013 |
| 93 | Epistaxis (HP:0000421) | 2.50341193 |
| 94 | Ketoacidosis (HP:0001993) | 2.49343816 |
| 95 | Hyperglycinuria (HP:0003108) | 2.48872233 |
| 96 | Microcytic anemia (HP:0001935) | 2.48184053 |
| 97 | Abnormality of purine metabolism (HP:0004352) | 2.48064144 |
| 98 | Epidermoid cyst (HP:0200040) | 2.46271641 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 2.44485969 |
| 100 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44485969 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 2.42638565 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 2.42208025 |
| 103 | Difficulty running (HP:0009046) | 2.42141741 |
| 104 | Chest pain (HP:0100749) | 2.41728055 |
| 105 | Gout (HP:0001997) | 2.41627000 |
| 106 | Abnormality of T cells (HP:0002843) | 2.41321257 |
| 107 | Hypoglycemic coma (HP:0001325) | 2.40308237 |
| 108 | Slow saccadic eye movements (HP:0000514) | 2.39509613 |
| 109 | Hypercholesterolemia (HP:0003124) | 2.38244274 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36980243 |
| 111 | Joint hemorrhage (HP:0005261) | 2.35283615 |
| 112 | Hypochromic anemia (HP:0001931) | 2.33564374 |
| 113 | Round ear (HP:0100830) | 2.33430814 |
| 114 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32653675 |
| 115 | Distal arthrogryposis (HP:0005684) | 2.32350044 |
| 116 | Hypochromic microcytic anemia (HP:0004840) | 2.32321258 |
| 117 | Osteomyelitis (HP:0002754) | 2.32092634 |
| 118 | Fat malabsorption (HP:0002630) | 2.29980686 |
| 119 | Obstructive sleep apnea (HP:0002870) | 2.29230465 |
| 120 | Progressive muscle weakness (HP:0003323) | 2.28832999 |
| 121 | Hemoptysis (HP:0002105) | 2.27764707 |
| 122 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.27528927 |
| 123 | Keratoconjunctivitis (HP:0001096) | 2.26695627 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24258106 |
| 125 | Anomalous pulmonary venous return (HP:0010772) | 2.22893962 |
| 126 | Polycythemia (HP:0001901) | 2.22366202 |
| 127 | Stridor (HP:0010307) | 2.20060144 |
| 128 | Abnormality of complement system (HP:0005339) | 2.19832860 |
| 129 | Urticaria (HP:0001025) | 2.19571102 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18557158 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18557158 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18557158 |
| 133 | Granulocytopenia (HP:0001913) | 2.18255951 |
| 134 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.18132787 |
| 135 | Type 1 muscle fiber predominance (HP:0003803) | 2.17785366 |
| 136 | Leukocytosis (HP:0001974) | 2.16405405 |
| 137 | Calf muscle hypertrophy (HP:0008981) | 2.16270756 |
| 138 | Gastrointestinal stroma tumor (HP:0100723) | 2.16069663 |
| 139 | Abnormality of the fingertips (HP:0001211) | 2.15624138 |
| 140 | Cerebral hypomyelination (HP:0006808) | 2.14192755 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12976037 |
| 142 | Systemic lupus erythematosus (HP:0002725) | 2.11927377 |
| 143 | Verrucae (HP:0200043) | 2.11649475 |
| 144 | Papilloma (HP:0012740) | 2.11649475 |
| 145 | Loss of speech (HP:0002371) | 2.11346283 |
| 146 | Amyloidosis (HP:0011034) | 2.10890000 |
| 147 | Cerebral inclusion bodies (HP:0100314) | 2.10094159 |
| 148 | Myocardial infarction (HP:0001658) | 2.09083299 |
| 149 | Lymphopenia (HP:0001888) | 2.08456762 |
| 150 | Abnormality of the Achilles tendon (HP:0005109) | 2.07976424 |
| 151 | Abnormality of T cell physiology (HP:0011840) | 2.07611937 |
| 152 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07025052 |
| 153 | Episodic fever (HP:0001954) | 2.06866427 |
| 154 | Mucopolysacchariduria (HP:0008155) | 2.06249015 |
| 155 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06249015 |
| 156 | Spastic paraparesis (HP:0002313) | 2.04911101 |
| 157 | Autoimmune hemolytic anemia (HP:0001890) | 2.03835131 |
| 158 | Papilledema (HP:0001085) | 2.03789944 |
| 159 | Pulmonary embolism (HP:0002204) | 2.01599535 |
| 160 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01427958 |
| 161 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01412365 |
| 162 | Purpura (HP:0000979) | 2.00827753 |
| 163 | Gingival bleeding (HP:0000225) | 2.00344037 |
| 164 | Autoimmune thrombocytopenia (HP:0001973) | 1.99869061 |
| 165 | Fatigue (HP:0012378) | 1.99784554 |
| 166 | Metabolic acidosis (HP:0001942) | 1.99777357 |
| 167 | Restrictive lung disease (HP:0002091) | 1.99125606 |
| 168 | Petechiae (HP:0000967) | 1.98886222 |
| 169 | Hematochezia (HP:0002573) | 1.95358055 |
| 170 | Recurrent bronchitis (HP:0002837) | 1.94833323 |
| 171 | Abnormality of serum amino acid levels (HP:0003112) | 1.93296642 |
| 172 | Arterial thrombosis (HP:0004420) | 1.92935129 |
| 173 | Paraparesis (HP:0002385) | 1.92920531 |
| 174 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.92058473 |
| 175 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.92058473 |
| 176 | Abnormality of the pulmonary veins (HP:0011718) | 1.91786966 |
| 177 | Acne (HP:0001061) | 1.91685127 |
| 178 | Late onset (HP:0003584) | 1.91671391 |
| 179 | Hemorrhage of the eye (HP:0011885) | 1.91285606 |
| 180 | Upper motor neuron abnormality (HP:0002127) | 1.91109218 |
| 181 | Brushfield spots (HP:0001088) | 1.90446744 |
| 182 | Neuronal loss in central nervous system (HP:0002529) | 1.89549203 |
| 183 | Hypergammaglobulinemia (HP:0010702) | 1.89493596 |
| 184 | Steatorrhea (HP:0002570) | 1.87621950 |
| 185 | Peripheral demyelination (HP:0011096) | 1.86929280 |
| 186 | Hyperuricemia (HP:0002149) | 1.82665272 |
| 187 | Increased purine levels (HP:0004368) | 1.82665272 |
| 188 | Abnormality of the intrinsic pathway (HP:0010989) | 1.81759478 |
| 189 | EMG: myopathic abnormalities (HP:0003458) | 1.81423050 |
| 190 | Asymmetric septal hypertrophy (HP:0001670) | 1.79143728 |
| 191 | Hepatic necrosis (HP:0002605) | 1.78080235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.88339058 |
| 2 | PRPF4B | 3.84431737 |
| 3 | EPHB1 | 3.74050710 |
| 4 | OBSCN | 2.96987849 |
| 5 | ERN1 | 2.85512203 |
| 6 | RIPK4 | 2.83537490 |
| 7 | INSRR | 2.67745076 |
| 8 | TAOK3 | 2.51080263 |
| 9 | TYK2 | 2.49582630 |
| 10 | TTN | 2.45733121 |
| 11 | CDK19 | 2.39447175 |
| 12 | TRIB3 | 2.28350530 |
| 13 | FGFR4 | 2.21130237 |
| 14 | FES | 2.20588356 |
| 15 | MAP3K14 | 2.07936241 |
| 16 | STK39 | 2.06253446 |
| 17 | MAP4K1 | 1.92202278 |
| 18 | MOS | 1.91138010 |
| 19 | MAP3K3 | 1.80559301 |
| 20 | IRAK4 | 1.79903125 |
| 21 | TNK2 | 1.78532816 |
| 22 | MAP2K3 | 1.69476705 |
| 23 | SIK3 | 1.69332244 |
| 24 | TAOK2 | 1.67055539 |
| 25 | TXK | 1.66459428 |
| 26 | MUSK | 1.55408179 |
| 27 | STK10 | 1.50887878 |
| 28 | KSR2 | 1.50345863 |
| 29 | DYRK3 | 1.50166795 |
| 30 | CDK12 | 1.49549205 |
| 31 | OXSR1 | 1.48748712 |
| 32 | MAP3K10 | 1.48218172 |
| 33 | PHKG1 | 1.39143340 |
| 34 | PHKG2 | 1.39143340 |
| 35 | MAPK11 | 1.38270348 |
| 36 | PKN1 | 1.37901493 |
| 37 | TBK1 | 1.34342006 |
| 38 | MAP3K7 | 1.33567496 |
| 39 | ICK | 1.33118314 |
| 40 | EEF2K | 1.29764490 |
| 41 | MAP3K6 | 1.28117838 |
| 42 | MARK2 | 1.23962915 |
| 43 | IRAK3 | 1.23395114 |
| 44 | PINK1 | 1.23088976 |
| 45 | MAPKAPK3 | 1.21618073 |
| 46 | PKN2 | 1.20743418 |
| 47 | PRKAA2 | 1.20117952 |
| 48 | JAK2 | 1.18160052 |
| 49 | SIK1 | 1.16182062 |
| 50 | SIK2 | 1.14626929 |
| 51 | EPHA3 | 1.13617976 |
| 52 | WNK4 | 1.12408872 |
| 53 | JAK1 | 1.12138118 |
| 54 | PIK3CG | 1.10444593 |
| 55 | DYRK1B | 1.08644574 |
| 56 | MARK3 | 1.04410207 |
| 57 | EIF2AK1 | 0.99419294 |
| 58 | TGFBR2 | 0.98165427 |
| 59 | LYN | 0.96447735 |
| 60 | MAPK12 | 0.96427287 |
| 61 | SMG1 | 0.96226136 |
| 62 | MAP2K6 | 0.94850733 |
| 63 | LRRK2 | 0.92323034 |
| 64 | BTK | 0.91136238 |
| 65 | CDC42BPA | 0.90440006 |
| 66 | PRKAA1 | 0.90145960 |
| 67 | CAMKK1 | 0.89455989 |
| 68 | MET | 0.89299548 |
| 69 | HIPK2 | 0.88810608 |
| 70 | FGFR3 | 0.88149995 |
| 71 | MAPK7 | 0.85956290 |
| 72 | ITK | 0.83134506 |
| 73 | NME1 | 0.82638111 |
| 74 | IRAK1 | 0.76484553 |
| 75 | IRAK2 | 0.76445586 |
| 76 | CSF1R | 0.75246139 |
| 77 | FLT3 | 0.74982849 |
| 78 | MAP3K9 | 0.74844444 |
| 79 | PTK6 | 0.74420093 |
| 80 | MAP2K4 | 0.73130668 |
| 81 | BMX | 0.72438012 |
| 82 | FGR | 0.72128367 |
| 83 | TESK2 | 0.72062665 |
| 84 | WNK1 | 0.71291499 |
| 85 | MAPK15 | 0.68433939 |
| 86 | RET | 0.67756841 |
| 87 | NLK | 0.67501417 |
| 88 | BRD4 | 0.65195137 |
| 89 | CHUK | 0.64741485 |
| 90 | MAP3K11 | 0.64716667 |
| 91 | RPS6KL1 | 0.64396559 |
| 92 | RPS6KC1 | 0.64396559 |
| 93 | TEC | 0.62833374 |
| 94 | RIPK1 | 0.62691844 |
| 95 | CSK | 0.61512586 |
| 96 | CAMK1D | 0.61174438 |
| 97 | GRK6 | 0.60666986 |
| 98 | NEK2 | 0.59115476 |
| 99 | KIT | 0.59040551 |
| 100 | IKBKE | 0.58063963 |
| 101 | TAOK1 | 0.57524984 |
| 102 | PDPK1 | 0.57352983 |
| 103 | MAP3K8 | 0.57180722 |
| 104 | PDK1 | 0.56944663 |
| 105 | SGK3 | 0.56562512 |
| 106 | STK4 | 0.54786139 |
| 107 | MATK | 0.53955448 |
| 108 | PDK2 | 0.53621336 |
| 109 | NME2 | 0.53279388 |
| 110 | MAP2K2 | 0.52032476 |
| 111 | PRKD1 | 0.51950639 |
| 112 | RPS6KA6 | 0.51636557 |
| 113 | JAK3 | 0.51186686 |
| 114 | TLK1 | 0.49478619 |
| 115 | BMPR2 | 0.49260120 |
| 116 | PASK | 0.48966411 |
| 117 | PRKCQ | 0.48864895 |
| 118 | FGFR2 | 0.47640938 |
| 119 | ZAP70 | 0.47184869 |
| 120 | CAMK2G | 0.46186489 |
| 121 | CDK4 | 0.44349388 |
| 122 | MAP3K13 | 0.42549010 |
| 123 | IKBKB | 0.42399002 |
| 124 | FYN | 0.42113334 |
| 125 | ERBB4 | 0.42096286 |
| 126 | SYK | 0.41367177 |
| 127 | MAP3K1 | 0.41231278 |
| 128 | PIM1 | 0.41220303 |
| 129 | BLK | 0.41197539 |
| 130 | MAPK4 | 0.40729825 |
| 131 | MAPKAPK2 | 0.39851448 |
| 132 | CAMKK2 | 0.37336382 |
| 133 | LCK | 0.37150283 |
| 134 | CAMK4 | 0.36532769 |
| 135 | RPS6KA2 | 0.36471635 |
| 136 | SGK2 | 0.35998401 |
| 137 | HCK | 0.35084076 |
| 138 | MAP3K2 | 0.33443666 |
| 139 | EIF2AK3 | 0.33368021 |
| 140 | MTOR | 0.32947732 |
| 141 | DYRK2 | 0.32557159 |
| 142 | PRKD2 | 0.31929500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.83434466 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69944317 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80918968 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.76723067 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.76014848 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60368115 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57965694 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51415113 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48795317 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.47657835 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47064165 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.41355656 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.37814616 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33439814 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.30961836 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23933368 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15818604 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10693728 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09902683 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 2.03956407 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98939525 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.95394372 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94913013 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.91663634 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90397307 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.90290256 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.80548640 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80103289 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.78513512 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78332529 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74192364 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.74083424 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73046138 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72295373 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67567121 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63893480 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63803533 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63590539 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62190512 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61806385 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60187151 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60101742 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58909291 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58863313 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.58587230 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56384023 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53557414 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.48804386 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46872296 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.46607865 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46475889 |
| 52 | Measles_Homo sapiens_hsa05162 | 1.44794756 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42469598 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41727644 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41589625 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40118984 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.40053331 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.38626475 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37722183 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37692576 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34911201 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33943948 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32861984 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32761635 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30392276 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29440103 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27439677 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26162371 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.25897831 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23152523 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21495051 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20131863 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17722054 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16266911 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14733074 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 1.14611054 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14444492 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 1.13265376 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12979733 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10664909 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10452068 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 1.08093494 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07269576 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05711012 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04497501 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 1.01424538 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00797384 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99983371 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99280997 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99107851 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99012700 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98746496 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97182662 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96861426 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95062657 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95054237 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93166954 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92685762 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.91715423 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89543307 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89018793 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86855128 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84518613 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81978576 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80339553 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.80165976 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79841797 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79326268 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76540020 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76516997 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76215507 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.75879218 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75086475 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72312664 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72289728 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.71154010 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71148365 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.70389566 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69759330 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.69165820 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69101082 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68851506 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68530105 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68000468 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66946288 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64530521 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63529355 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63058382 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.62452148 |
| 130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62297492 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62103872 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61797382 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61170409 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59632575 |
| 135 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58894018 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58855512 |
| 137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58515916 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56102035 |
| 139 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54915960 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54168011 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53925647 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53533466 |
| 143 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51019083 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50335830 |
| 145 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49155738 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.49004341 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48934527 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.48832749 |
| 149 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47788522 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47018366 |
| 151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46994328 |
| 152 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46729439 |
| 153 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45112617 |
| 154 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43356934 |
| 155 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43255033 |
| 156 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43236199 |
| 157 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42442282 |
| 158 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41992762 |
| 159 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41907904 |
| 160 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38644638 |
| 161 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34151652 |
| 162 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31074981 |
| 163 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25274323 |
| 164 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24839793 |
| 165 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23556306 |
| 166 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19611954 |
| 167 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17984362 |
| 168 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.17878331 |
| 169 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.12939344 |
| 170 | Pertussis_Homo sapiens_hsa05133 | 0.10730509 |
| 171 | Prion diseases_Homo sapiens_hsa05020 | 0.08826535 |
| 172 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08028037 |
| 173 | Hepatitis C_Homo sapiens_hsa05160 | 0.07680017 |
| 174 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.07471307 |
| 175 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.04534306 |
| 176 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04488456 |
| 177 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04154881 |
| 178 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01894636 |
| 179 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.01836977 |
| 180 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01796273 |

